Amaç: Bu çalışmadaki amacımız obezitenin göstergesi olan prepatellar subkutan yağ kalınlığı (PSYK) ile kondromalazik patellanın (KP) varlığı ve şiddeti arasındaki ilişkiyi belirlemektir. Gereç-Yöntem: Retrospektif olan bu çalışmaya 9 aylık dönemde çeşitli nedenlerle diz manyetik rezonans görüntüleme (MRG ) yapılan ve kritelere uyan 175 hasta dahil edildi. Çekimler 1.5 T MRG cihazında ekstremite koili kullanılarak yapıldı. KP değerlendirmesi için aksiyal kesitler kullanıldı ve grade 0 ( normal) ile grade 3 (komplet kartilaj kaybı) arasında derecelendirildi. PSYK ölçümünde ise sagittal kesitler kullanıldı. Bulgular: KP 25 olguda grade 1 (%33,33), 25 olguda grade 2 (%33,33) ve 25 olguda grade 3 (%33,33) olmak üzere 75 hastada (%42.8) saptandı. KP grubunda PSYK normal gruba göre yüksekti (P<.001). KP'nın grade ile PSYK arasında pozitif korelasyon gösterildi ( R=0,47 [95% confidence interval,1,20-2,12] p<.001 ). Subkutanöz prepatellar yağ dokusu kadınlarda belirgin kalındı ( P<.001). Sonuç: Obezitenin göstergesi olan PSYK ile KP 'nın varlığı ve şiddeti arasında pozitif ilişki mevcuttur.
The aim of this study was to evaluate trochlear morphology in patients with medial patellar cartilage defects via magnetic resonance imaging (MRI).
Three hundred patients who were diagnosed with grade 2, 3 and 4 medial patellar cartilage defect using MRI according to the International Cartilage Repair Society Classification System and 100 control subjects were evaluated. Trochlear morphology was evaluated based on lateral trochlear inclination (LTI), medial trochlear inclination (MTI), sulcus angle( SA), femoral lateral and medial condyle symmetry, trochlear facet asymmetry, and trochlear width on the axial MR images.
The mean SA was significantly higher in the medial patellar cartilage defect group compared to the control group (p<.05). The LTI and MTI of the cartilage defect group were significantly lower than those of the control group (p<.05). With the decreasing LTI and MTI, there was an increase in medial patellar cartilage loss. LTI (r=-0.46) and MTI (r=-0.53) were moderately correlated with SA. There was no significant differences in femoral lateral and medial condyle symmetry, trochlear facet asymmetry, and trochlear width between groups with and without medial patellar cartilge defect (p > .05).
A flattened medial trochlea is a risk factor for cartilage structural damage of the medial patellofemoral joint, and it plays a role in the development of a defect in the medial patellar cartilage. The medial patellar cartilage defect is associated with the flattened lateral trochlea.
:
Cystic lymphangioma presenting with multiple bone lesions in an adult patient is a rare occurrence, with a
limited number of reported cases in the literature. In this case report, we describe a 32-year old female patient with
chronic neck and pelvic pain, and multiple lytic bone lesions on radiological imaging, which were eventually discovered
to originate from cystic hygroma and widespread bone lymphangiomas that were present for more than 10 years. It should
be kept in mind that there may be benign causes in the differential diagnosis in patients presenting with findings
suggestive of diffuse bone metastasis.Because misdiagnosis may cause the patient to receive unnecessary treatments,
especially radiotherapy. In this case, we reached the diagnosis of benign disease, diffuse bone lymphangiomatosis, and the
long and stable medical history of the patient with the findings of BT, ultrasound and bone scintigraphy.
We think that as long as there are no stable and serious results in the company with the clinical and radiological findings
of the patient, it should be approached with medical follow-up without treatment.
scite is a Brooklyn-based organization that helps researchers better discover and understand research articles through Smart Citations–citations that display the context of the citation and describe whether the article provides supporting or contrasting evidence. scite is used by students and researchers from around the world and is funded in part by the National Science Foundation and the National Institute on Drug Abuse of the National Institutes of Health.